JPRN-UMIN000027770RecruitingPhase 1
Phase I/Ib study of Ad-SGE-REIC-GH in patient with liver cancer. - Phase I study of Ad-SGE-REIC-GH in patient with liver cancer.
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Okayama University Hospital
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient with active bacterial, fungal or viral infections. Hepatitis B or C is allowed Patient with brain metastasis Patient with other malignancies HIV-positive Patient with angina pectoris, congestive heart failure, or myocardial infarction less than 1 year previously Patient with psychiatric illness that would limit compliance with study requirements Pregnant women, women suspect she is pregnant, or lactating woman Patient have a history of allergic reactions against drugs used in this study Any experimental anti-cancer drug therapy within 4weeks prior to this study Any anti-cancer drug therapy within 4 weeks prior to this study Patient received topical therapy within 4 weeks prior to this study Patient on anticoagulation or antiplatelet therapy Poor glycemic control measured as HbA1C >8.0 Patient is on chronic systemic steroid therapy
Investigators
Similar Trials
Active, not recruiting
Phase 1
A phase I/IIa study of Ad-SGE-REIC-NS in patient with recurrent malignant gliomareccurent malignant gliomaJPRN-jRCT2063190013Fujii Kentaro18
Unknown
Phase 1
Phase I/II clinical trialMalignant pleural mesotheliomaJPRN-jRCT2080222946Kyorin Pharmaceutical Co.,LTD18
Active, not recruiting
Phase 1
A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive EpisodeBipolar II DisorderMedDRA version: 26.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-006861-39-NLGH Research Ireland Limited15
Recruiting
Phase 1
A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive EpisodeBipolar II DisorderMedDRA version: 26.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-006861-39-DEGH Research Ireland Limited15
Unknown
Phase 1
Phase I Clinical Study of RG7304 in Patients with Advanced Solid TumorsJPRN-jRCT2080221452Chugai Pharmaceutical Co., Ltd.30